Active surveillance for prostate cancer: current evidence and contemporary state of practice
Crossref DOI link: https://doi.org/10.1038/nrurol.2016.45
Published Online: 2016-03-08
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tosoian, Jeffrey J.
Carter, H. Ballentine
Lepor, Abbey
Loeb, Stacy
Text and Data Mining valid from 2016-03-08
Version of Record valid from 2016-03-08
Article History
First Online: 8 March 2016
Competing interests
: S.L. has acted as an advisor for Bayer Corp. The other authors declare no competing interests.